Eli Lilly and Company

About

We are a medicine company. From groundbreaking research to record investments in U.S. manufacturing, we ruthlessly prioritize giving everyone a chance at health. In 2025 alone, we helped more than 71 million people find the care, medicine, and well-being they needed. Around the world, we are 50,000 employees strong, dedicated to putting health above all.

Verified company data

Cash position

$9,353.4 million

Shares outstanding

943,357,420

Projects

["not discovered"]

Leadership

Ralph Alvarez (not discovered), Katherine Baicker, Ph.D. (not discovered), Carolyn Bertozzi, Ph.D. (not discovered), Erik Fyrwald (not discovered), Mary Lynne Hedley, Ph.D. (not discovered), Jamere Jackson (not discovered), Kimberly Johnson (not discovered), William Kaelin, Jr., M.D. (not discovered), Juan Luciano (not discovered), Jon Moeller (not discovered), David Ricks (not discovered), Gabrielle Sulzberger (not discovered)

Verified data last updated: 2026-08-14

Recent filings

• Notice of proposed sale of securities pursuant to Rule 1442026-08-17 · lly_2026-08-17_20-06-30.pdf→
• Statement of changes in beneficial ownership of securities2026-08-11 · lly_2026-08-11_19-31-56.pdf→
• Statement of changes in beneficial ownership of securities2026-08-10 · lly_2026-08-10_19-19-22.pdf→
• Notice of proposed sale of securities pursuant to Rule 1442026-08-07 · lly_2026-08-07_13-30-00.pdf→
• General form for quarterly reports under Section 13 or 15(d)2026-08-05 · lly_2026-08-05_17-40-40.pdf→
• Current report pursuant to Section 13 or 15(d)2026-08-05 · lly_2026-08-05_10-05-09.pdf→
• Statement of changes in beneficial ownership of securities2026-08-03 · lly_2026-08-03_19-42-34.pdf→
• [Amend] Statement of acquisition of beneficial ownership by individuals2026-07-23 · lly_2026-07-23_13-12-10.pdf→